Overview

Single-Dose Versus Multi-Dose Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

Status:
Enrolling by invitation

Trial end date:
2023-06-30

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to evaluate the outcomes of differing durations of antibiotic prophylaxis with bladder onabotulinumtoxinA injection in patients with refractory overactive bladder. The main question it aims to answer are: • Is the incidence of post-procedure UTI similar between single-dose and multi-day durations of peri-procedural antibiotics? Participants will be randomized to single-dose versus multi-day dose of antibiotic prophylaxis with bladder onabotulinumtoxinA injection. Researchers will compare incidence of UTI in each group to see if there is a significant difference.

Phase:

Phase 4

Details

Lead Sponsor:

The Cleveland Clinic

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular